Argatroban Injection

• • Argatroban intravenous injection, Fresenius Kabi, 100 mg/mL, 2.5 mL vial, 1 count, NDC 63323-0526-03
  • Argatroban intravenous injection, Mylan Institutional (Viatris), 100 mg/mL, 2.5 mL vial, 1 count, NDC 67457-0212-02
  • Argatroban intravenous injection, Pfizer, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00409-1140-01

• • Eugia did not provide a reason for the shortage.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Hikma did not provide a reason for the shortage.
  • Viatris did not provide a reason for the shortage.
  • Novartis discontinued argatroban.
  • Par has argatroban available.
  • Pfizer has argatroban on shortage due to manufacturing delays.
  • Sagent did not provide a reason for the shortage.
  • Sandoz discontinued argatroban 1 mg/mL 50 mL vials in April 2019. Sandoz discontinued argatroban 1 mg/mL 125 mL vials in April 2020.
  • Teva is not marketing argatroban.

• • Argatroban intravenous injection, Eugia US, 1 mg/mL, 50 mL vial, 10 count, NDC 55150-0241-10
  • Argatroban intravenous injection, Hikma, 1 mg/mL, 50 mL vial, 1 count, NDC 00143-9559-01
  • Argatroban intravenous injection, Hikma, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00143-9674-01
  • Argatroban intravenous injection, Par Pharmaceuticals, 100 mg/mL, 2.5 mL vial, 1 count, NDC 42023-0182-01
  • Argatroban intravenous injection, Sagent, 1 mg/mL, 50 mL vial, 1 count, NDC 25021-0414-50

Estimated Resupply Dates

• • Fresenius Kabi has argatroban 100 mg/mL 2.5 mL vials on back order and the company cannot estimate a release date.
  • Pfizer has argatroban 100 mg/mL 2.5 mL vials available in limited supply.
  • Viatris has argatroban 100 mg/mL 2.5 mL vials on back order and the company estimates a release date of mid- to late-February 2023.